The University of Kansas;Oregon Health & Science University
发明人:
申请号:
EP15857472.3
公开号:
EP3215152A4
申请日:
2015.11.04
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.